← European Medicine Shortage Tracker · all medicines

Pioglitazonhydrochlorid shortage — availability across Europe

Availability information only — Mobi Doctor doesn't sell medicines; check with a pharmacy.

MEDICALLY REVIEWED
Dr. Chrysoula I. Liakou MD, PhD
Internal Medicine Specialist
Cancer Immunology Researcher
Reviewed 30 July 2026 · next review due 30 January 2027

Pioglitazonhydrochlorid currently has availability issues reported in 3 European registers: Germany, Spain, Italy.

Shortage  ATC A10BG03 · also listed as: Pioglitazonhydrochlorid · PIOGLITAZONA · PIOGLITAZONE · data refreshed 9 September 2026

Key facts

As of 9 September 2026, 3 of the 9 tracked registers list current availability issues for Pioglitazonhydrochlorid, covering 7 affected product presentations. The longest-running open report was filed in Italy on 2026-06-01 and has now been open for about 3 months. Where agencies state a cause, manufacturing problems lead with 6 of the 6 stated-cause reports. The furthest expected-resolution date currently on file is 2026-12-15; the earliest is 2026-10-29. Momentum is current, not historical: 6 of the open reports were filed within the last 90 days. Registers in Germany, Spain, Italy indicate that alternatives or equivalents are available — a pharmacist or doctor can advise on switching. In the WHO ATC classification, Pioglitazonhydrochlorid is coded A10BG03 — a medicine acting on alimentary tract and metabolism — so clinically related products appear under “Related medicines” below.

WhereStatus & productsSinceExpected end Reason / alternativesSource
🇩🇪 GermanyShortage
Actos 15 mg Tabletten - OP112
2026-06-302026-10-31Herstellerwechsel
Alternatives: N/A
register ↗
🇪🇸 SpainShortage
PIOGLITAZONA CINFA 15 MG COMPRIMIDOS EFG, 56 comprimidos
2026-08-132026-10-29Existen otros medicamentos con el mismo principio activo y misma vía.
Alternatives: Existe/n otro/s medicamento/s con el mismo principio activo y para la misma vía de administración.
register ↗
🇮🇹 ItalyShortage
ACTOS
+ 4 more products
PIOGLITAZONE ACCORD
PIOGLITAZONE AUROBINDO
PIOGLITAZONE MYLAN
PIOGLITAZONE MYLAN
2026-06-012026-12-15Problemi produttivi
Alternatives: AIFA: equivalents with the same active substance are available.
register ↗

New register reports per month

2026-06: 32026-07: 12026-08: 12026-09: 12026-062026-09

Full report history (7 register entries)

Every individual register entry for Pioglitazonhydrochlorid in the tracked sources, newest first — including resolved and discontinued reports.

Reg.ProductStatusReportedExpected endStated reason
🇮🇹 ITPIOGLITAZONE MYLANShortage2026-10-25Problemi produttivi
🇮🇹 ITACTOSShortage2026-09-102026-12-15Problemi produttivi
🇪🇸 ESPIOGLITAZONA CINFA 15 MG COMPRIMIDOS EFG, 56 comprimidosShortage2026-08-132026-10-29Existen otros medicamentos con el mismo principio activo y m
🇮🇹 ITPIOGLITAZONE ACCORDShortage2026-07-31Problemi produttivi
🇩🇪 DEActos 15 mg Tabletten - OP112Shortage2026-06-302026-10-31Herstellerwechsel
🇮🇹 ITPIOGLITAZONE MYLANShortage2026-06-16Problemi produttivi
🇮🇹 ITPIOGLITAZONE AUROBINDOShortage2026-06-01Problemi produttivi

Frequently asked

Is Pioglitazonhydrochlorid currently in shortage in Europe?

Yes. As of 9 September 2026, availability issues are reported in: Germany, Spain, Italy. Availability is national — a shortage in one country does not mean it is short everywhere.

When is the Pioglitazonhydrochlorid shortage expected to end?

Agency prognoses on file range from 2026-10-29 to 2026-12-15. These are manufacturer-reported estimates and frequently move; check the linked register entry for the latest date.

Are there alternatives to Pioglitazonhydrochlorid?

7 of the active register entries indicate alternatives or equivalents (same active substance or an alternative treatment). Do not switch on your own — a pharmacist or prescriber can confirm the right substitute in your country.

Where does this Pioglitazonhydrochlorid availability data come from?

Directly from the official medicines-agency registers that list Pioglitazonhydrochlorid: BfArM (Germany), AEMPS CIMA (Spain), AIFA (Italy). Every row on this page links to the underlying official record, and the dataset is refreshed from the primary sources every morning. Cross-language matching groups the same active substance across registers, so national spellings all resolve to this page.

Related medicines (same ATC class)

Embed this tracker

Pharmacies, patient sites and newsrooms are welcome to embed the live status of Pioglitazonhydrochlorid — free, with attribution. Copy this snippet:

<iframe src="https://www.mobidoctor.eu/medicine-shortages/medicine-shortages/pioglitazonhydrochlorid/embed.html" width="100%" height="150" loading="lazy" style="border:1px solid #e1e0d9;border-radius:12px" title="Pioglitazonhydrochlorid availability in Europe"></iframe>
<p style="font-size:12px">Source: <a href="https://www.mobidoctor.eu/medicine-shortages/medicine-shortages/pioglitazonhydrochlorid/">Pioglitazonhydrochlorid shortage status — European Medicine Shortage Tracker</a> by MobiDoctor</p>
Cite: “Pioglitazonhydrochlorid: availability status across 3 European registers — European Medicine Shortage Tracker (MobiDoctor), 9 September 2026.” Link this page and the agency record. Statuses come from the linked official registers and can change daily.